Search - tctmd.com

Displaying 101 - 120 of 713

Sort: Relevancy | Date

News Conference News EAS 2023

Variable Response to Novel PCSK9 Inhibitor Lerodalcibep in LIBERATE-HoFH

Michael O'Riordan

May 24, 2023

News Conference News EAS 2023

High LDL, Poor Treatment, Early Death: HoFH Registry Paints Grim Picture

Michael O'Riordan

May 23, 2023

News Conference News EuroPCR 2023

‘Fascinating’ Unlocking Coronary Stent Prompts Cautious Praise

Michael O'Riordan

May 18, 2023

News Daily News

Oxidized Phospholipids and Lp(a) Strongly Associated With MACE: CASABLANCA

Michael O'Riordan

May 03, 2023

News Daily News

TCTMD’s Top 10 Most Popular Stories for April 2023

Shelley Wood

April 28, 2023

News Daily News

Breast Cancer Deaths Lower With Statin Therapy, Taiwanese Data Hint

Caitlin E. Cox

April 26, 2023

News Daily News

REPRIEVE Stopped: Big MACE Reductions With Statins in HIV+ Subjects

Shelley Wood

April 12, 2023

News Daily News

To Improve CV Care in US South Asians, Understand Unique ASCVD Risks: ACC

Yael L. Maxwell

April 12, 2023

News Daily News

PROMISE II: Flow-Diverting Procedure May Save Limbs in CLTI

L.A. McKeown

March 29, 2023

News Daily News

MI Risk in Subclinical CAD? Both Extent and Stenosis Severity Matter

Yael L. Maxwell

March 27, 2023

News Daily News

Longer and Greater Risk Factor Exposure, More CVD

Caitlin E. Cox

March 23, 2023

News Conference News ACC 2023

CRP More Predictive of Future Events Than LDL in Statin-Treated Patients

Caitlin E. Cox

March 14, 2023

News Conference News ACC 2023

Oral PCSK9 Inhibitor Reduces LDL Cholesterol in Phase IIb Study

Todd Neale

March 10, 2023

News Conference News ACC 2023

MASTER@HEART: Long-term Endurance Athletes Not Immune to Atherosclerosis

Michael O'Riordan

March 10, 2023

News Conference News ACC 2023

Stable CAD Plaque Morphology Improved by PCSK9 Inhibitors: YELLOW III

Shelley Wood

March 04, 2023

News Daily News

Only Half of Revascularized PAD Patients Receive GDMT

L.A. McKeown

February 14, 2023

News Daily News

Maternal CV Risk After Adverse Pregnancy Outcome Can Last Over 40 Years

L.A. McKeown

February 13, 2023

News Conference News ISC 2023

Continuous Monitoring Finds AF Up to 3 Years After Noncryptogenic Stroke

Todd Neale

February 08, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2023

Caitlin E. Cox

February 01, 2023

News Daily News

UK’s NICE Recommends Lower-Risk Thresholds for Statin Therapy

Michael O'Riordan

January 20, 2023

Advertisement

Variable Response to Novel PCSK9 Inhibitor Lerodalcibep in LIBERATE-HoFH

High LDL, Poor Treatment, Early Death: HoFH Registry Paints Grim Picture

‘Fascinating’ Unlocking Coronary Stent Prompts Cautious Praise

Oxidized Phospholipids and Lp(a) Strongly Associated With MACE: CASABLANCA

TCTMD’s Top 10 Most Popular Stories for April 2023

Breast Cancer Deaths Lower With Statin Therapy, Taiwanese Data Hint

REPRIEVE Stopped: Big MACE Reductions With Statins in HIV+ Subjects

To Improve CV Care in US South Asians, Understand Unique ASCVD Risks: ACC

PROMISE II: Flow-Diverting Procedure May Save Limbs in CLTI

MI Risk in Subclinical CAD? Both Extent and Stenosis Severity Matter

Longer and Greater Risk Factor Exposure, More CVD

CRP More Predictive of Future Events Than LDL in Statin-Treated Patients

Oral PCSK9 Inhibitor Reduces LDL Cholesterol in Phase IIb Study

MASTER@HEART: Long-term Endurance Athletes Not Immune to Atherosclerosis

Stable CAD Plaque Morphology Improved by PCSK9 Inhibitors: YELLOW III

Only Half of Revascularized PAD Patients Receive GDMT

Maternal CV Risk After Adverse Pregnancy Outcome Can Last Over 40 Years

Continuous Monitoring Finds AF Up to 3 Years After Noncryptogenic Stroke

TCTMD’s Top 10 Most Popular Stories for January 2023

UK’s NICE Recommends Lower-Risk Thresholds for Statin Therapy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content